申请人:Smith D. Nicholas
公开号:US20070135431A1
公开(公告)日:2007-06-14
Disclosed herein are carbonyl compounds of having the structural formula:
or a salt, ester, or prodrug thereof, Methods and compositions are disclosed for treating disease states including, but not limited to cancers, autoimmune diseases, tissue damage, central nervous system disorders, neurodegenerative disorders, fibrosis, bone disorders, polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, cardiovascular conditions, and disorders in which angiogenesis play a role in pathogenesis, using the compounds of the invention. In addition, methods of modulating the activity of histone deacetylase (HDAC) are also disclosed.
本公开涉及具有结构式的羰基化合物:或其盐、酯或前药,揭示了用于治疗疾病状态的方法和组合物,包括但不限于癌症、自身免疫疾病、组织损伤、中枢神经系统疾病、神经退行性疾病、纤维化、骨疾病、多谷氨酸重复疾病、贫血、地中海贫血、炎症症状、心血管疾病以及血管生成在病因中起作用的疾病,使用本发明的化合物。此外,还揭示了调节组蛋白去乙酰化酶(HDAC)活性的方法。